NEW YORK, NY / ACCESSWIRE / November 25, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to ...

Designed for patients needing a replacement valve, the company’s TAVI trial has found low rates of mortality after a year of ...

Analyst Josh Jennings from TD Cowen maintained a Hold rating on Edwards Lifesciences (EW – Research Report) and keeping the price target at ...

Edwards Lifesciences (NYSE:EW) today announced one-year data highlighting strong performance from its Sapien 3 Ultra Resilia ...

Edwards Lifesciences Co. (NYSE:EW – Free Report) – Zacks Research dropped their Q1 2025 EPS estimates for shares of Edwards ...

Abbott has taken a step forward in the development of a new addition to its structural heart portfolio, completing the first ...

For many investors, the main point of stock picking is to generate higher returns than the overall market. But in ...

On Friday, Edwards Lifesciences Corp (EW) stock saw a modest uptick, ending the day at $70.48 which represents a slight increase of $0.10 or 0.14% from the prior close of $70.38. The stock opened at ...

Edwards Lifesciences Co. has a 52 week low of $58.93 and a 52 week high of $96.12. The company has a market cap of $41.01 billion, a PE ratio of 10.03, a P/E/G ratio of 3.81 and a beta of 1.12.

EW STOCK NEWS: Edwards Lifesciences Stock Plummeted 31% - Contact BFA Law About The Class Action Lawsuit If You Suffered Losses (NYSE:EW) ...

Class Action Lawsuit Against Edwards Lifesciences Corporation (EW): The litigation is focused on the propriety of Edwards Lifesciences' disclosures about its core product, the Transcatheter Aortic ...